JVLIX
Price
$22.51
Change
-$2.79 (-11.03%)
Updated
Dec 20 closing price
RMFCX
Price
$54.73
Change
+$0.55 (+1.02%)
Updated
Dec 20 closing price
Ad is loading...

JVLIX vs RMFCX

Header iconJVLIX vs RMFCX Comparison
Open Charts JVLIX vs RMFCXBanner chart's image
JHancock Disciplined Value I
Price$22.51
Change-$2.79 (-11.03%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.73
Change+$0.55 (+1.02%)
VolumeN/A
CapitalizationN/A
JVLIX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVLIX vs. RMFCX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVLIX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. JVLIX (13.4B). RMFCX pays higher dividends than JVLIX: RMFCX (1.69) vs JVLIX (0.94). JVLIX was incepted earlier than RMFCX: JVLIX (28 years) vs RMFCX (23 years). JVLIX is a more actively managed with annual turnover of: 43.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than JVLIX: RMFCX (250) vs JVLIX (250000). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. JVLIX (3.49). RMFCX return over 5 years is better than : 37.80 vs. JVLIX (12.00).
JVLIXRMFCXJVLIX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years23 years-
Gain YTD2.5619.92126%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.4B102B13%
Annual Yield % from dividends0.941.6955%
Returns for 1 year3.4911.1131%
Returns for 3 years0.5612.385%
Returns for 5 years12.0037.8032%
Returns for 10 years25.5859.3643%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA